WEDNESDAY, Sept. 18, 2024 -- Monthly use of erenumab injections (140 mg) is safe and effective in achieving medication overuse headache (MOH)...
Vous n'êtes pas connecté
TUESDAY, June 25, 2024 -- For patients with prurigo nodularis (PN) and chronic pruritus of unknown origin (CPUO), abrocitinib, a Janus kinase 1 inhibitor, is effective and well tolerated, according to a study published online June 5 in JAMA...
WEDNESDAY, Sept. 18, 2024 -- Monthly use of erenumab injections (140 mg) is safe and effective in achieving medication overuse headache (MOH)...
TUESDAY, Sept. 24, 2024 -- Long-term use of skeletal muscle relaxants (SMRs) for chronic pain is only effective for certain conditions, such as...
TUESDAY, Sept. 17, 2024 -- For postoperative patients with breast cancer, the duration of aromatase inhibitor (AI) treatment is not associated with...
MONDAY, Sept. 16, 2024 -- There is a bidirectional association for anxiety and depression with chronic rhinosinusitis (CRS), according to a study...
TUESDAY, Sept. 17, 2024 -- A new prognostic model can predict and stratify hepatocellular carcinoma (HCC) risk in noncirrhotic adult patients with...
WEDNESDAY, Sept. 18, 2024 -- For patients with type 2 diabetes, sodium-glucose cotransporter 2 inhibitor (SGLT2i) use is associated with reduced...
FRIDAY, Sept. 20, 2024 -- For veterans with incident chronic kidney disease (CKD), a history of homelessness is associated with an increased risk for...
TUESDAY, Sept. 24, 2024 -- There is a J-shaped association between systemic immune-inflammation index (SII) levels and all-cause mortality in...
MONDAY, Sept. 16, 2024 -- Among youth with chronic pain, a number of individuals are diagnosed with anxiety and depression when compared with their...
TUESDAY, Sept. 24, 2024 -- Few U.S. jails offer medications for opioid use disorder (MOUD), according to a study published online Sept. 24 in JAMA...